Stability of peroxide antimalarials in the presence of human hemoglobin

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3496-3500

  Creek, Darren J ^a   Ryan, Eileen ^a   Charman, William N ^a   Chiu, Francis C K ^a   Prankerd, Richard J ^a   Vennerstrom, Jonathan L ^b   Charman, Susan A ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; DIHYDROARTEMISININ; HEME; OXYHEMOGLOBIN; OZ 277; OZ 78; UNCLASSIFIED DRUG;

ARTICLE; DRUG STABILITY; DRUG STRUCTURE; OXIDATION; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN SECRETION;

ANTIMALARIALS; ARTEMISININS; DRUG STABILITY; HEMOGLOBINS; HUMANS; MOLECULAR STRUCTURE; PEROXIDES; SPECTROPHOTOMETRY;

EID: 67749142076     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00363-09     Document Type: Article

References (39)

1. Bakhshi, H. B., T. Gordi, and M. Ashton. 1997. In-vitro interaction of artemisinin with intact human erythrocytes, erythrocyte ghosts, haemoglobin and carbonic anhydrase. J. Pharm. Pharmacol. 49:223-226.
2. Benesch, R. E., R. Benesch, and S. Yung. 1973. Equations for the spectrophotometric analysis of hemoglobin mixtures. Anal. Biochem. 55:245-248.
3. Benesch, R. E., and S. Kwong. 1995. Coupled reactions in hemoglobin. J. Biol. Chem. 270:13785-13786.
4. Creek, D. J., W. N. Charman, F. C. K. Chiu, R. J. Prankerd, Y. Dong, J. L. Vennerstrom, and S. A. Charman. 2008. Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4- trioxolane antimalarials. Antimicrob. Agents Chemother. 52:1291-1296.
5. Creek, D. J., W. N. Charman, F. C. K. Chiu, R. J. Prankerd, K. J. McCullough, Y. Dong, J. L. Vennerstrom, and S. A. Charman. 2007. Iron-mediated degradation kinetics of substituted dispiro-1,2,4-trioxolane antimalarials. J. Pharm. Sci. 96:2945-2956.
6. Creek, D. J., F. C. K. Chiu, R. J. Prankerd, S. A. Charman, and W. N. Charman. 2005. Kinetics of iron-mediated artemisinin degradation: effect of solvent composition and iron salt. J. Pharm. Sci. 94:1820-1829.
7. Di Iorio, E. E. 1981. Preparation of derivatives of ferrous and ferric hemoglobin. Methods Enzymol 76:57-72.
8. Francis, S. E., D. J. Sullivan, and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
9. Golenser, J., J. H. Waknine, M. Krugliak, N. H. Hunt, and G. E. Grau. 2006. Current perspectives on the mechanism of action of artemisinins. Int. J. Parasitol. 36:1427-1441.
10. Hargrove, M. S., T. Whitaker, J. S. Olson, R. J. Vali, and A. J. Mathews. 1997. Quaternary structure regulates hemin dissociation from human hemoglobin. J. Biol. Chem. 272:17385-17389.
11. Harrington, J. P. 1998. Alteration of redox stability of hemoglobins A and S by biological buffers. Comp. Biochem. Physiol. B 119:305-309.
12. Harrington, J. P., and L. Keaton. 1993. Unfolding and release of heme from human hemoglobins A, S and F. Int. J. Biochem. 25:661-664.
13. Jefford, C. W. 2007. New developments in synthetic peroxidic drugs as artemisinin mimics. Drug Discov. Today 12:487-495.
14. Kannan, R., K. Kumar, D. Sahal, S. Kukreti, and V. S. Chauhan. 2004. Reaction of artemisinin with hemoglobin: implications for antimalarial activity. Biochem. J. 385:409-418.
15. Krishna, S., C. J. Woodrow, H. M. Staines, R. K. Haynes, and O. Mercereau-Puijalon. 2006. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends Mol. Med. 12:200-205.
16. Liu, S. C., S. Zhai, and J. Palek. 1988. Detection of hemin release during hemoglobin S denaturation. Blood 71:1755-1758.
17. Luo, Z.-D., and C.-C. Shen. 1987. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med. Res. Rev. 7:29-52.
18. Macdonald, V. W. 1994. Measuring relative rates of hemoglobin oxidation and denaturation. Methods Enzymol. 231:480-490.
19. Meshnick, S. R. 2002. Artemisinin: mechanisms of action, resistance and toxicity. Int. J. Parasitol. 32:1655-1660.
20. Meshnick, S. R., A. Thomas, A. Ranz, C.-M. Xu, and H.-Z. Pan. 1991. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol. Biochem. Parasitol. 49:181-189.
21. Messori, L., C. Gabbiani, A. Casini, M. Siragusa, F. F. Vincieri, and A. R. Bilia. 2006. The reaction of artemisinins with hemoglobin: a unified picture. Bioorg. Med. Chem. 14:2972-2977.
22. O'Neill, P. M. 2005. The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents. Exp. Opin. Investig. Drugs 14:1117-1128.
23. O'Neill, P. M., and G. H. Posner. 2004. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 47:2945-2964.
24. Olsen, K. W. 1994. Thermal denaturation procedures for hemoglobin. Methods Enzymol. 231:514-524.
25. Olson, J. S., and C. Binger. 1976. The effect of ligand size and stereochemistry on the reactivity of the α and β chains within hemoglobin. Biochim. Biophys. Acta 434:428-439.
26. Park, S.-Y., T. Yokoyama, N. Shibayama, Y. Shiro, and J. R. H. Tame. 2006. 1.25 Å resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy forms. J. Mol. Biol. 360:690-701.
27. Perry, C., S. A. Charman, R. J. Prankerd, F. C. K. Chiu, Y. Dong, J. L. Vennerstrom, and W. N. Charman. 2006. Chemical kinetics and aqueous degradation pathways of a new class of synthetic ozonide antimalarials. J. Pharm. Sci. 95:737-747.
28. Ponmee, N., T. Chuchue, P. Wilairat, Y. Yuthavong, and S. Kamchonwongpaisan. 2007. Artemisinin effectiveness in erythrocytes is reduced by heme and heme-containing proteins. Biochem. Pharmacol. 74:153-160.
29. Robert, A., F. Benoit-Vical, and B. Meunier. 2005. The key role of heme to trigger the antimalarial activity of trioxanes. Coord. Chem. Rev. 249:1927-1936.
30. Selmeczi, K., A. Robert, C. Claparols, and B. Meunier. 2004. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin. FEBS Lett. 556:245-248.
31. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
32. Stephanos, J. J. 1996. Drug-protein interactions: two-site binding of heterocyclic ligands to a monomeric hemoglobin. J. Inorg. Biochem. 62:155-169.
33. Stephanos, J. J., S. A. Farina, and A. W. Addison. 1996. Iron ligand recognition by monomeric hemoglobins. Biochim. Biophys. Acta 1295:209-221.
34. Sugawara, Y., E. Kadono, A. Suzuki, Y. Yukuta, Y. Shibasaki, N. Nishimura, Y. Kameyama, M. Hirota, C. Ishida, N. Higuchi, K. Haramoto, Y. Sakai, and H. Soda. 2003. Hemichrome formation observed in human haemoglobin A under various buffer conditions. Acta Physiol. Scand. 179:49-59.
35. Talbot, B., M. Brunori, E. Antonini, and J. Wyman. 1971. Studies on the reaction of isocyanides with haemproteins. I. Equilibria and kinetics of the binding to the isolated chains of human haemoglobin. J. Mol. Biol. 58:263-276.
36. Vennerstrom, J. L., S. Arbe-Barnes, R. Brun, S. A. Charman, F. C. K. Chiu, J. Chollet, Y. Dong, A. Dorn, D. Hunziker, H. Matile, K. McIntosh, M. Padmanilayam, J. Santo Tomas, C. Scheurer, B. Scorneaux, Y. Tang, H. Urwyler, S. Wittlin, and W. N. Charman. 2004. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430:900-904.
37. Xu, Y., Y. Zheng, J.-S. Fan, and D. Yang. 2006. A new strategy for structure determination of large proteins in solution without deuteration. Nat. Methods 3:931-937.
38. Yang, Y. Z., B. Little, and S. R. Meshnick. 1994. Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure. Biochem. Pharmacol. 48:569-573.
39. Zhang, S., and G. S. Gerhard. 2008. Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin. Bioorg. Med. Chem. 16:7853-7861.